Expand ADAP Menu
ADAP MENU

ADAP Stock Summary and Trading Ideas (Adaptimmune Therapeutics PLC - American Depositary Shares | NASDAQ:ADAP)

Charts for Today's Stock Price and Implied Volatility in Adaptimmune Therapeutics PLC - American Depositary Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ADAP by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Adaptimmune Therapeutics PLC - American Depositary Shares (ADAP) Frequently Asked Questions

What does Adaptimmune Therapeutics PLC - American Depositary Shares do?

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

What symbol and exchange does Adaptimmune Therapeutics PLC - American Depositary Shares shares trade?

Adaptimmune Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol ADAP.

What is Adaptimmune Therapeutics PLC - American Depositary Shares stock price doing today?

As of January 29, 2025, ADAP stock price declined to $0.58 with 312,900 million shares trading.

What is Adaptimmune Therapeutics PLC - American Depositary Shares's Beta?

ADAP has a beta of 2.91, meaning it tends to be more sensitive to market movements. ADAP has a correlation of 0.17 to the broad based SPY ETF.

How much is Adaptimmune Therapeutics PLC - American Depositary Shares worth?

ADAP has a market cap of $149.05 million. This is considered a Micro Cap stock.

How much money does Adaptimmune Therapeutics PLC - American Depositary Shares make?

Last quarter Adaptimmune Therapeutics PLC - American Depositary Shares reported $41 million in Revenue and -$.07 earnings per share. This beat revenue expectation by $30 million and exceeded earnings estimates by $.06.

What is the highest and lowest price Adaptimmune Therapeutics PLC - American Depositary Shares traded in the last 3 year period?

In the last 3 years, ADAP traded as high as $3.32 and as low as $.42.

What are the top ETFs holding Adaptimmune Therapeutics PLC - American Depositary Shares?

The top ETF exchange traded funds that ADAP belongs to (by Net Assets): SPDW, FESM, GWX, QQQS.

Is Adaptimmune Therapeutics PLC - American Depositary Shares (ADAP) a good investment?

ADAP has underperformed the market in the last year with a price return of -20.2% while the SPY ETF gained +24.9%. ADAP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.0% and -1.3%, respectively, while the SPY returned +4.0% and +3.4%, respectively.

What are the support and resistance levels for Adaptimmune Therapeutics PLC - American Depositary Shares (ADAP)?

ADAP support price is $.56 and resistance is $.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADAP shares will trade within this expected range on the day.